Erasca Aims For $263 Million IPO
janiecbros/E+ via Getty Images
Quick Take
Erasca (ERAS) has filed to raise $263 million in an IPO of its common stock, according to an S-1/A registration statement.
The firm is a clinical stage biopharma developing treatments for a wide variety of solid…
